Keros Therapeutics Ownership 2024 | Who Owns Keros Therapeutics Now?
Institutional Ownership
48.57%
Insider Ownership
5.86%
Retail Ownership
45.57%
Institutional Holders
73.00
Keros Therapeutics Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| FMR LLC | 16.03% | 0.01% | 4,719,760 | -298,756 | -5.95% | 215,693,033 | Jun 30, 2024 |
| BLACKROCK INC. | 8.53% | 0.00% | 2,513,244 | 347,234 | 16.03% | 114,855,253 | Jun 30, 2024 |
| VANGUARD GROUP INC | 5.97% | 0.00% | 1,757,120 | 211,362 | 13.67% | 80,300,383 | Jun 30, 2024 |
| ALKEON CAPITAL MANAGEMENT LLC | 5.43% | 0.12% | 1,598,907 | - | - | 73,070,050 | Jun 30, 2024 |
| DARWIN GLOBAL MANAGEMENT, LTD. | 5.18% | 8.00% | 1,525,902 | 89,952 | 6.26% | 68,772,403 | Jun 30, 2024 |
| ORBIMED ADVISORS LLC | 4.31% | 1.15% | 1,268,734 | - | - | 57,981,144 | Jun 30, 2024 |
| STATE STREET CORP | 4.15% | 0.00% | 1,221,376 | -341,519 | -21.85% | 55,816,883,000 | Jun 30, 2024 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 4.03% | 0.01% | 1,187,910 | -30,594 | -2.51% | 54,288,000 | Jun 30, 2024 |
| BRAIDWELL LP | 3.34% | 1.41% | 982,209 | 244,830 | 33.20% | 44,886,951 | Jun 30, 2024 |
| JEFFERIES FINANCIAL GROUP INC. | 3.05% | 0.44% | 899,077 | 265,406 | 41.88% | 41,087,819 | Jun 30, 2024 |
| TCG CROSSOVER MANAGEMENT, LLC | 2.99% | 4.19% | 879,344 | - | - | 40,186,021 | Jun 30, 2024 |
| WOODLINE PARTNERS LP | 2.63% | 0.34% | 775,845 | 14,145 | 1.86% | 35,456,117 | Jun 30, 2024 |
| HOLOCENE ADVISORS, LP | 2.34% | 0.13% | 688,326 | 50,343 | 7.89% | 31,456,498 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.31% | 0.00% | 679,580 | 83,734 | 14.05% | 31,063,079 | Jun 30, 2024 |
| REDMILE GROUP, LLC | 1.88% | 1.53% | 552,506 | - | - | 25,249,524 | Jun 30, 2024 |
| ADAR1 CAPITAL MANAGEMENT, LLC | 1.86% | 4.74% | 548,916 | 210,673 | 62.28% | 25,085,461 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 1.77% | 0.00% | 521,447 | 263,079 | 101.82% | 23,830,128 | Jun 30, 2024 |
| EVENTIDE ASSET MANAGEMENT, LLC | 1.70% | 0.39% | 499,208 | -180,792 | -26.59% | 22,813,806 | Jun 30, 2024 |
| CANDRIAM S.C.A. | 1.50% | 0.12% | 441,855 | -210,144 | -32.23% | 20,191,831 | Jun 30, 2024 |
| FRANKLIN RESOURCES INC | 1.36% | 0.01% | 400,214 | -231,835 | -36.68% | 18,289,780 | Jun 30, 2024 |
Keros Therapeutics's largest institutional shareholder is FMR LLC, holding 16.03% of the company's total share outstanding, currently valued at $215.69M. The top 10 institutional shareholders own together 60.02% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| DARWIN GLOBAL MANAGEMENT, LTD. | 5.18% | 8.00% | 1,525,902 | 89,952 | 6.26% | 68,772,403 | Jun 30, 2024 |
| ADAR1 CAPITAL MANAGEMENT, LLC | 1.86% | 4.74% | 548,916 | 210,673 | 62.28% | 25,085,461 | Jun 30, 2024 |
| SUPERSTRING CAPITAL MANAGEMENT LP | 0.25% | 4.28% | 74,288 | 40,460 | 119.61% | 3,394,962 | Jun 30, 2024 |
| TCG CROSSOVER MANAGEMENT, LLC | 2.99% | 4.19% | 879,344 | - | - | 40,186,021 | Jun 30, 2024 |
| OPALEYE MANAGEMENT INC. | 1.25% | 3.84% | 367,500 | - | - | 16,794,750 | Jun 30, 2024 |
| BLUE OWL CAPITAL HOLDINGS LP | 0.54% | 2.00% | 157,633 | -15,000 | -8.69% | 7,203,828 | Jun 30, 2024 |
| REDMILE GROUP, LLC | 1.88% | 1.53% | 552,506 | - | - | 25,249,524 | Jun 30, 2024 |
| BRAIDWELL LP | 3.34% | 1.41% | 982,209 | 244,830 | 33.20% | 44,886,951 | Jun 30, 2024 |
| PARKMAN HEALTHCARE PARTNERS LLC | 0.67% | 1.22% | 198,627 | 20,292 | 11.38% | 9,077,254 | Jun 30, 2024 |
| ORBIMED ADVISORS LLC | 4.31% | 1.15% | 1,268,734 | - | - | 57,981,144 | Jun 30, 2024 |
| NANTAHALA CAPITAL MANAGEMENT, LLC | 1.29% | 1.02% | 378,807 | 84,810 | 28.85% | 17,311,480 | Jun 30, 2024 |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 0.75% | 0.89% | 221,600 | -52,000 | -19.01% | 10,127,120 | Jun 30, 2024 |
| DAFNA CAPITAL MANAGEMENT LLC | 0.23% | 0.74% | 67,754 | - | - | 3,096,358 | Jun 30, 2024 |
| AVIDITY PARTNERS MANAGEMENT LP | 1.17% | 0.67% | 343,200 | 133,500 | 63.66% | 15,684,240 | Jun 30, 2024 |
| HIGHVISTA STRATEGIES LLC | 0.13% | 0.65% | 39,208 | - | - | 1,791,806 | Jun 30, 2024 |
| EDBI PTE LTD | 0.03% | 0.52% | 10,105 | - | - | 461,799 | Jun 30, 2024 |
| JEFFERIES FINANCIAL GROUP INC. | 3.05% | 0.44% | 899,077 | 265,406 | 41.88% | 41,087,819 | Jun 30, 2024 |
| EVENTIDE ASSET MANAGEMENT, LLC | 1.70% | 0.39% | 499,208 | -180,792 | -26.59% | 22,813,806 | Jun 30, 2024 |
| INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 0.29% | 0.37% | 85,000 | 45,000 | 112.50% | 3,884,500 | Jun 30, 2024 |
| WOODLINE PARTNERS LP | 2.63% | 0.34% | 775,845 | 14,145 | 1.86% | 35,456,117 | Jun 30, 2024 |
The largest Keros Therapeutics shareholder by % of total assets is DARWIN GLOBAL MANAGEMENT, LTD.. The company owns 1.53M shares of Keros Therapeutics (KROS), representing 8.00% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BLACKROCK INC. | 8.53% | 0.00% | 2,513,244 | 347,234 | 16.03% | 114,855,253 | Jun 30, 2024 |
| JEFFERIES FINANCIAL GROUP INC. | 3.05% | 0.44% | 899,077 | 265,406 | 41.88% | 41,087,819 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 1.77% | 0.00% | 521,447 | 263,079 | 101.82% | 23,830,128 | Jun 30, 2024 |
| BRAIDWELL LP | 3.34% | 1.41% | 982,209 | 244,830 | 33.20% | 44,886,951 | Jun 30, 2024 |
| VANGUARD GROUP INC | 5.97% | 0.00% | 1,757,120 | 211,362 | 13.67% | 80,300,383 | Jun 30, 2024 |
| ADAR1 CAPITAL MANAGEMENT, LLC | 1.86% | 4.74% | 548,916 | 210,673 | 62.28% | 25,085,461 | Jun 30, 2024 |
| D. E. SHAW & CO., INC. | 0.60% | 0.01% | 175,695 | 156,821 | 830.88% | 8,029,262 | Jun 30, 2024 |
| AVIDITY PARTNERS MANAGEMENT LP | 1.17% | 0.67% | 343,200 | 133,500 | 63.66% | 15,684,240 | Jun 30, 2024 |
| DARWIN GLOBAL MANAGEMENT, LTD. | 5.18% | 8.00% | 1,525,902 | 89,952 | 6.26% | 68,772,403 | Jun 30, 2024 |
| NANTAHALA CAPITAL MANAGEMENT, LLC | 1.29% | 1.02% | 378,807 | 84,810 | 28.85% | 17,311,480 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.31% | 0.00% | 679,580 | 83,734 | 14.05% | 31,063,079 | Jun 30, 2024 |
| BALYASNY ASSET MANAGEMENT L.P. | 0.30% | 0.01% | 88,636 | 63,124 | 247.43% | 4,050,665 | Jun 30, 2024 |
| AMERICAN CENTURY COMPANIES INC | 1.01% | 0.01% | 298,170 | 59,364 | 24.86% | 13,626,423 | Jun 30, 2024 |
| ALLIANCEBERNSTEIN L.P. | 0.51% | 0.00% | 150,462 | 58,604 | 63.80% | 6,876,113 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 1.33% | 0.01% | 392,956 | 55,293 | 16.38% | 17,958,089 | Jun 30, 2024 |
| HOLOCENE ADVISORS, LP | 2.34% | 0.13% | 688,326 | 50,343 | 7.89% | 31,456,498 | Jun 30, 2024 |
| TWINBEECH CAPITAL LP | 0.17% | 0.04% | 48,988 | 48,988 | 100.00% | 2,238,752 | Jun 30, 2024 |
| MORGAN STANLEY | 1.14% | 0.00% | 335,669 | 46,512 | 16.09% | 15,340,074 | Jun 30, 2024 |
| INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 0.29% | 0.37% | 85,000 | 45,000 | 112.50% | 3,884,500 | Jun 30, 2024 |
| SUPERSTRING CAPITAL MANAGEMENT LP | 0.25% | 4.28% | 74,288 | 40,460 | 119.61% | 3,394,962 | Jun 30, 2024 |
As of Jun 30 2024, Keros Therapeutics's largest institutional buyer is BLACKROCK INC.. The company purchased 347.23K stocks of KROS, valued at $114.86M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| POINT72 ASSET MANAGEMENT, L.P. | 1.26% | 0.04% | 370,350 | -601,531 | -61.89% | 16,924,991 | Jun 30, 2024 |
| STATE STREET CORP | 4.15% | 0.00% | 1,221,376 | -341,519 | -21.85% | 55,816,883,000 | Jun 30, 2024 |
| FMR LLC | 16.03% | 0.01% | 4,719,760 | -298,756 | -5.95% | 215,693,033 | Jun 30, 2024 |
| MARSHALL WACE, LLP | 0.08% | 0.00% | 22,377 | -250,594 | -91.80% | 1,022,629 | Jun 30, 2024 |
| FRANKLIN RESOURCES INC | 1.36% | 0.01% | 400,214 | -231,835 | -36.68% | 18,289,780 | Jun 30, 2024 |
| CANDRIAM S.C.A. | 1.50% | 0.12% | 441,855 | -210,144 | -32.23% | 20,191,831 | Jun 30, 2024 |
| CIBC WORLD MARKETS CORP | - | - | - | -200,000 | -100.00% | - | Jun 30, 2024 |
| EVENTIDE ASSET MANAGEMENT, LLC | 1.70% | 0.39% | 499,208 | -180,792 | -26.59% | 22,813,806 | Jun 30, 2024 |
| INVESCO LTD. | 0.04% | 0.00% | 11,865 | -76,818 | -86.62% | 542,231 | Jun 30, 2024 |
| RAFFERTY ASSET MANAGEMENT, LLC | 0.20% | 0.01% | 57,555 | -61,956 | -51.84% | 2,630,264 | Jun 30, 2024 |
| UBS GROUP AG | 0.22% | 0.00% | 65,555 | -58,630 | -47.21% | 2,995,864 | Jun 30, 2024 |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 0.75% | 0.89% | 221,600 | -52,000 | -19.01% | 10,127,120 | Jun 30, 2024 |
| HSBC HOLDINGS PLC | - | - | - | -46,419 | -100.00% | - | Jun 30, 2024 |
| BARCLAYS PLC | 0.08% | 0.00% | 24,992 | -44,664 | -64.12% | 1,141,000 | Jun 30, 2024 |
| HUDSON BAY CAPITAL MANAGEMENT LP | 0.10% | 0.01% | 30,038 | -35,400 | -54.10% | 1,372,737 | Jun 30, 2024 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 4.03% | 0.01% | 1,187,910 | -30,594 | -2.51% | 54,288,000 | Jun 30, 2024 |
| SCHONFELD STRATEGIC ADVISORS LLC | 0.12% | 0.01% | 34,113 | -26,292 | -43.53% | 1,558,963 | Jun 30, 2024 |
| JPMORGAN CHASE & CO | 0.10% | 0.00% | 30,695 | -24,715 | -44.60% | 1,402,762 | Jun 30, 2024 |
| CAPTION MANAGEMENT, LLC | - | - | - | -23,600 | -100.00% | - | Jun 30, 2024 |
| FRED ALGER MANAGEMENT, LLC | 0.17% | 0.01% | 48,993 | -16,887 | -25.63% | 2,238,980 | Jun 30, 2024 |
As of Jun 30 2024, Keros Therapeutics's biggest institutional seller is POINT72 ASSET MANAGEMENT, L.P.. The company sold -0.60M shares of KROS, valued at $16.92M.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| TWINBEECH CAPITAL LP | 0.17% | 0.04% | 48,988 | 48,988 | 100.00% | 2,238,752 | Jun 30, 2024 |
| PFM HEALTH SCIENCES, LP | 0.11% | 0.08% | 33,355 | 33,355 | 100.00% | 1,524,324 | Jun 30, 2024 |
| ASSENAGON ASSET MANAGEMENT S.A. | 0.08% | 0.00% | 24,459 | 24,459 | 100.00% | 1,117,776 | Jun 30, 2024 |
| ARTIA GLOBAL PARTNERS LP | 0.07% | 0.18% | 20,000 | 20,000 | 100.00% | 914,000 | Jun 30, 2024 |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | 0.07% | 0.01% | 19,940 | 19,940 | 100.00% | 911,000 | Jun 30, 2024 |
| SQUAREPOINT OPS LLC | 0.07% | 0.00% | 19,832 | 19,832 | 100.00% | 906,322 | Jun 30, 2024 |
| POINT72 (DIFC) LTD | 0.06% | 0.03% | 17,540 | 17,540 | 100.00% | 801,594 | Jun 30, 2024 |
| COREBRIDGE FINANCIAL, INC. | 0.05% | 0.00% | 15,852 | 15,852 | 100.00% | 724,436 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 0.05% | 0.00% | 15,183 | 15,183 | 100.00% | 692,498 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 0.05% | 0.00% | 14,300 | 14,300 | 100.00% | 653,510 | Jun 30, 2024 |
| JUMP FINANCIAL, LLC | 0.05% | 0.01% | 13,681 | 13,681 | 100.00% | 625,222 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 0.03% | 0.00% | 10,000 | 10,000 | 100.00% | 457,000 | Jun 30, 2024 |
| NEBULA RESEARCH & DEVELOPMENT LLC | 0.03% | 0.06% | 8,254 | 8,254 | 100.00% | 377,208 | Jun 30, 2024 |
| DARK FOREST CAPITAL MANAGEMENT LP | 0.02% | 0.05% | 6,355 | 6,355 | 100.00% | 290,424 | Jun 30, 2024 |
| EXCHANGE TRADED CONCEPTS, LLC | 0.02% | 0.01% | 5,167 | 5,167 | 100.00% | 236,132 | Jun 30, 2024 |
| XTX TOPCO LTD | 0.02% | 0.02% | 4,996 | 4,996 | 100.00% | 228,317 | Jun 30, 2024 |
| POINT72 ASIA (SINGAPORE) PTE. LTD. | 0.01% | 0.03% | 2,811 | 2,811 | 100.00% | 128,451 | Jun 30, 2024 |
| AQUATIC CAPITAL MANAGEMENT LLC | 0.00% | 0.00% | 1,200 | 1,200 | 100.00% | 54,840 | Jun 30, 2024 |
| CWM, LLC | 0.00% | - | 25 | 25 | 100.00% | 1,000 | Jun 30, 2024 |
| INNEALTA CAPITAL, LLC | 0.00% | 0.00% | 22 | 22 | 100.00% | 1,005 | Jun 30, 2024 |
| SRS CAPITAL ADVISORS, INC. | 0.00% | 0.00% | 16 | 16 | 100.00% | 732 | Jun 30, 2024 |
Keros Therapeutics's largest new institutional shareholder by number of shares is TWINBEECH CAPITAL LP, purchased 48.99K shares, valued at $2.24M, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| CIBC WORLD MARKETS CORP | - | - | - | -200,000 | -100.00% | - | Jun 30, 2024 |
| HSBC HOLDINGS PLC | - | - | - | -46,419 | -100.00% | - | Jun 30, 2024 |
| CAPTION MANAGEMENT, LLC | - | - | - | -23,600 | -100.00% | - | Jun 30, 2024 |
| AMERICAN INTERNATIONAL GROUP, INC. | - | - | - | -12,653 | -100.00% | - | Jun 30, 2024 |
| GSA CAPITAL PARTNERS LLP | - | - | - | -8,538 | -100.00% | - | Jun 30, 2024 |
| FORA CAPITAL, LLC | - | - | - | -8,480 | -100.00% | - | Jun 30, 2024 |
| LIGHTHOUSE INVESTMENT PARTNERS, LLC | - | - | - | -7,593 | -100.00% | - | Jun 30, 2024 |
| PERPETUAL LTD | - | - | - | -6,689 | -100.00% | - | Jun 30, 2024 |
| E FUND MANAGEMENT CO., LTD. | - | - | - | -5,648 | -100.00% | - | Jun 30, 2024 |
| BAYESIAN CAPITAL MANAGEMENT, LP | - | - | - | -4,029 | -100.00% | - | Jun 30, 2024 |
| ENVESTNET ASSET MANAGEMENT INC | - | - | - | -3,798 | -100.00% | - | Jun 30, 2024 |
| LMR PARTNERS LLP | - | - | - | -3,671 | -100.00% | - | Jun 30, 2024 |
| PICTET ASSET MANAGEMENT HOLDING SA | - | - | - | -3,527 | -100.00% | - | Jun 30, 2024 |
| VICTORY CAPITAL MANAGEMENT INC | - | - | - | -3,513 | -100.00% | - | Jun 30, 2024 |
| METROPOLITAN LIFE INSURANCE CO/NY | - | - | - | -1,353 | -100.00% | - | Jun 30, 2024 |
| RIGGS ASSET MANAGMENT CO. INC. | - | - | - | -5 | -100.00% | - | Jun 30, 2024 |
| NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC | - | - | - | -4 | -100.00% | - | Jun 30, 2024 |
| PRINCIPAL SECURITIES, INC. | - | - | - | -3 | -100.00% | - | Jun 30, 2024 |
Keros Therapeutics's largest sold out institutional shareholder by shares sold is CIBC WORLD MARKETS CORP, sold -0.20M shares, valued at -, as of undefined.
Keros Therapeutics Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| Tema ETF Trust | 0.21% | 9,529 | 9,529 | - | Feb 29, 2024 |
| T. Rowe Price New Horizons Fund, Inc. | 0.19% | 926,383 | 114,798 | 14.14% | Mar 31, 2024 |
| FIDELITY ADVISOR SERIES VII | 0.10% | 829,600 | 140,100 | 20.32% | Jan 31, 2024 |
| Advantage Advisers Xanthus Fund, L.L.C. | 0.08% | 228,889 | 18,130 | 8.60% | Mar 31, 2024 |
| ACAP Strategic Fund | 0.05% | 784,099 | 48,187 | 6.55% | Mar 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND IV | 0.04% | 100,000 | 30,000 | 42.86% | Mar 31, 2024 |
| VANGUARD VALLEY FORGE FUNDS | 0.03% | 15,069 | - | - | Mar 31, 2024 |
| BlackRock Health Sciences Trust II | 0.03% | 74,602 | -49,318 | -39.80% | Mar 31, 2024 |
| FRANKLIN STRATEGIC SERIES | 0.03% | 220,450 | 30,799 | 16.24% | Jan 31, 2024 |
| AMERICAN CENTURY MUTUAL FUNDS, INC. | 0.02% | 205,264 | 8,842 | 4.50% | Jan 31, 2024 |
| FIDELITY CAPITAL TRUST | 0.02% | 191,200 | 3,500 | 1.86% | Jan 31, 2024 |
| FIDELITY SELECT PORTFOLIOS | 0.02% | 1,055,129 | 323,900 | 44.30% | Feb 29, 2024 |
| Humankind Benefit Corp | 0.01% | 311 | 33 | 11.87% | Dec 31, 2023 |
| FIDELITY SECURITIES FUND | 0.01% | 1,237,083 | 174,600 | 16.43% | Jan 31, 2024 |
| Federated Hermes MDT Series | 0.01% | 23,588 | - | - | Jan 31, 2024 |
| FIDELITY MT VERNON STREET TRUST | 0.01% | 218,535 | - | - | Feb 29, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.01% | 44,998 | 3,635 | 8.79% | Mar 31, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.01% | 3,783 | 348 | 10.13% | Mar 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND III | 0.01% | 44,000 | - | - | Mar 31, 2024 |
| FIDELITY COMMONWEALTH TRUST | 0.00% | 12,449 | 186 | 1.52% | Feb 29, 2024 |
| Fidelity Central Investment Portfolios LLC | 0.00% | 190,000 | 70,000 | 58.33% | Mar 31, 2024 |
| Nushares ETF Trust | 0.00% | 24,316 | 4,597 | 23.31% | Jan 31, 2024 |
| VANGUARD INDEX FUNDS | 0.00% | 1,197,007 | -297,383 | -19.90% | Mar 31, 2024 |
| VANGUARD EXPLORER FUND | 0.00% | 31,245 | - | - | Jan 31, 2024 |
| FIDELITY ADVISOR SERIES I | 0.00% | 423,700 | 65,200 | 18.19% | Feb 29, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND | 0.00% | 48,000 | 13,000 | 37.14% | Mar 31, 2024 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.00% | 400 | - | - | Mar 31, 2024 |
| ETFis Series Trust I | 0.00% | 2,431 | -130 | -5.08% | Jan 31, 2024 |
| ALPS ETF Trust | 0.00% | 21,126 | 168 | 0.80% | Feb 29, 2024 |
| SCHWAB CAPITAL TRUST | 0.00% | 62,517 | -929 | -1.46% | Jan 31, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 225,477 | 7,946 | 3.65% | Feb 29, 2024 |
| FIDELITY CONTRAFUND | 0.00% | 68,700 | 68,700 | - | Mar 31, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 2,560 | 324 | 14.49% | Mar 31, 2024 |
| FIRST TRUST EXCHANGE-TRADED FUND | 0.00% | 8,176 | 8,176 | - | Mar 31, 2024 |
| Destra Investment Trust | 0.00% | 1,362 | 1,362 | - | Mar 31, 2024 |
| BNY Mellon Strategic Funds, Inc. | 0.00% | 1,590 | 1,590 | - | Feb 29, 2024 |
| ProFunds | 0.00% | 6,267 | 2,419 | 62.86% | Mar 31, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 15,607 | 556 | 3.69% | Mar 31, 2024 |
| Ultimus Managers Trust | 0.00% | 5,697 | - | - | Feb 29, 2024 |
| Direxion Shares ETF Trust | 0.00% | 62,676 | 17,021 | 37.28% | Jan 31, 2024 |
| GOLDMAN SACHS VARIABLE INSURANCE TRUST | 0.00% | 1,449 | -2,144 | -59.67% | Mar 31, 2024 |
| VANGUARD WORLD FUND | 0.00% | 84,606 | 14,153 | 20.09% | Feb 29, 2024 |
| Principal Exchange-Traded Funds | 0.00% | 3,612 | -298 | -7.62% | Mar 31, 2024 |
| FIDELITY COVINGTON TRUST | 0.00% | 5,273 | - | - | Feb 29, 2024 |
| BlackRock ETF Trust | 0.00% | 238 | 9 | 3.93% | Jan 31, 2024 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 5,926 | 313 | 5.58% | Mar 31, 2024 |
| STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 1,229 | 108 | 9.63% | Mar 31, 2024 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 7,993 | -1,207 | -13.12% | Mar 31, 2024 |
| Global X Funds | 0.00% | 9,927 | - | - | Jan 31, 2024 |
| Fidelity Rutland Square Trust II | 0.00% | 268,640 | 253,810 | 1711.46% | Feb 29, 2024 |
| AMG FUNDS III | 0.00% | 1,124 | - | - | Mar 28, 2024 |
| Dimensional ETF Trust | 0.00% | 92,779 | -198 | -0.21% | Jan 31, 2024 |
| SCHWAB STRATEGIC TRUST | 0.00% | 122,231 | 6,366 | 5.49% | Feb 29, 2024 |
| CLEARWATER INVESTMENT TRUST | 0.00% | 1,959 | 1,959 | - | Mar 28, 2024 |
| RUSSELL INVESTMENT CO | 0.00% | 59,484 | 12,852 | 27.56% | Jan 31, 2024 |
| PUTNAM ASSET ALLOCATION FUNDS | 0.00% | 6,168 | -96 | -1.53% | Mar 31, 2024 |
| MUTUAL FUND SERIES TRUST | 0.00% | 680,000 | 100,000 | 17.24% | Mar 31, 2024 |
| AMERICAN CENTURY STRATEGIC ASSET ALLOCATIONS INC | 0.00% | 2,093 | 305 | 17.06% | Jan 31, 2024 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 9,347 | 1,800 | 23.85% | Mar 31, 2024 |
| TIAA-CREF LIFE FUNDS | 0.00% | 337 | - | - | Mar 31, 2024 |
| VANGUARD VARIABLE INSURANCE FUNDS | 0.00% | 6,058 | - | - | Mar 31, 2024 |
| SunAmerica Specialty Series | 0.00% | 57 | - | - | Apr 30, 2021 |
| VARIABLE INSURANCE PRODUCTS FUND II | 0.00% | 1,327 | 114 | 9.40% | Mar 31, 2024 |
| PRUDENTIAL INVESTMENT PORTFOLIOS, INC. | 0.00% | 1,000 | - | - | Mar 28, 2024 |
| USAA MUTUAL FUNDS TRUST | 0.00% | 23,977 | 21,663 | 936.17% | Jan 31, 2024 |
| BNY Mellon ETF Trust | 0.00% | 2,467 | 282 | 12.91% | Feb 29, 2024 |
| NORTHERN FUNDS | 0.00% | 13,766 | 1,363 | 10.99% | Mar 28, 2024 |
| BNY MELLON FUNDS TRUST | 0.00% | 6,526 | 6,526 | - | Feb 29, 2024 |
| Virtus Investment Trust | 0.00% | 2,953 | - | - | Mar 28, 2024 |
| iSHARES TRUST | 0.00% | 1,089,283 | 96,337 | 9.70% | Mar 31, 2024 |
| GPS Funds I | 0.00% | 307 | - | - | Mar 31, 2024 |
| NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 7,012 | 3,440 | 96.30% | Mar 31, 2024 |
| VANGUARD SCOTTSDALE FUNDS | 0.00% | 103,407 | 12,987 | 14.36% | Feb 29, 2024 |
| EQ ADVISORS TRUST | 0.00% | 61,586 | 4,446 | 7.78% | Mar 31, 2024 |
| RYDEX SERIES FUNDS | 0.00% | 205 | - | - | Dec 31, 2023 |
| FLEXSHARES TRUST | 0.00% | 3,652 | 2,908 | 390.86% | Jan 31, 2024 |
| RUSSELL INVESTMENT FUNDS | 0.00% | 4,589 | -1,228 | -21.11% | Mar 31, 2024 |
| J.P. Morgan Exchange-Traded Fund Trust | 0.00% | 14,720 | 2,157 | 17.17% | Jan 31, 2024 |
| MASTER INVESTMENT PORTFOLIO | 0.00% | 2,854 | 1,412 | 97.92% | Mar 31, 2024 |
| VALIC Co I | 0.00% | 8,638 | -35 | -0.40% | Feb 29, 2024 |
| PENN SERIES FUNDS INC | 0.00% | 800 | 100 | 14.29% | Mar 28, 2024 |
| SPDR SERIES TRUST | 0.00% | 995,773 | 413,366 | 70.98% | Mar 31, 2024 |
| RYDEX DYNAMIC FUNDS | 0.00% | 102 | - | - | Dec 31, 2023 |
| DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 25,658 | -17,452 | -40.48% | Jan 31, 2024 |
| Invesco Exchange-Traded Self-Indexed Fund Trust | 0.00% | 5,340 | - | - | Feb 29, 2024 |
| PROSHARES TRUST | 0.00% | 5,837 | 1,035 | 21.55% | Feb 29, 2024 |
| NATIONWIDE MUTUAL FUNDS | 0.00% | 3,014 | -853 | -22.06% | Jan 31, 2024 |
| HC CAPITAL TRUST | 0.00% | 704 | - | - | Mar 31, 2024 |
| RBB FUND, INC. | 0.00% | 1,506 | - | - | Feb 29, 2024 |
| Guggenheim Active Allocation Fund | 0.00% | 92 | - | - | Feb 29, 2024 |
| TIAA-CREF FUNDS | 0.00% | 41,902 | - | - | Jan 31, 2024 |
| SEASONS SERIES TRUST | 0.00% | 285 | - | - | Mar 31, 2024 |
| PGIM ETF TRUST | 0.00% | 753 | - | - | Feb 29, 2024 |
| ALLIANZ VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 613 | - | - | Dec 31, 2023 |
| RYDEX VARIABLE TRUST | 0.00% | 13 | - | - | Dec 31, 2023 |
| TRUST FOR PROFESSIONAL MANAGERS | 0.00% | 3,400 | 3,400 | - | Feb 29, 2024 |
| Brighthouse Funds Trust II | 0.00% | 8,284 | 725 | 9.59% | Mar 31, 2024 |
| MORGAN STANLEY PATHWAY FUNDS | 0.00% | 918 | - | - | Feb 29, 2024 |
| COLLEGE RETIREMENT EQUITIES FUND | 0.00% | 8,516 | - | - | Mar 31, 2024 |
| LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 19,377 | - | - | Mar 31, 2024 |
Keros Therapeutics's largest mutual fund holder by % of total assets is "Tema ETF Trust", owning 9.53K shares, compromising 0.21% of its total assets.
Keros Therapeutics Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 73 | -51.33% |
| 31 Mar, 24 | 150 | 23.97% |
| 31 Dec, 23 | 121 | 14.15% |
| 30 Sep, 23 | 106 | -13.82% |
| 30 Jun, 23 | 123 | -6.11% |
| 31 Mar, 23 | 131 | 3.15% |
| 31 Dec, 22 | 127 | 13.39% |
| 30 Sep, 22 | 112 | 9.80% |
| 30 Jun, 22 | 102 | -3.77% |
| 31 Mar, 22 | 106 | 7.07% |
| 31 Dec, 21 | 99 | 13.79% |
| 30 Sep, 21 | 87 | 11.54% |
| 30 Jun, 21 | 78 | -6.02% |
| 31 Mar, 21 | 83 | 3.75% |
| 31 Dec, 20 | 80 | 63.27% |
| 30 Sep, 20 | 49 | -3.92% |
| 30 Jun, 20 | 51 | - |
As of 30 Jun 24, 73 institutions are holding Keros Therapeutics's shares, representing a decrease of -51.33% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 14,302,112 | -54.40% |
| 31 Mar, 24 | 31,360,893 | 21.87% |
| 31 Dec, 23 | 25,732,585 | 12.83% |
| 30 Sep, 23 | 22,805,528 | 1.76% |
| 30 Jun, 23 | 22,410,603 | 1.88% |
| 31 Mar, 23 | 21,997,549 | 11.19% |
| 31 Dec, 22 | 19,783,180 | 9.46% |
| 30 Sep, 22 | 18,073,618 | 4.14% |
| 30 Jun, 22 | 17,354,802 | 5.54% |
| 31 Mar, 22 | 16,443,720 | 1.81% |
| 31 Dec, 21 | 16,151,318 | 17.08% |
| 30 Sep, 21 | 13,795,249 | -2.26% |
| 30 Jun, 21 | 14,114,722 | -2.03% |
| 31 Mar, 21 | 14,407,813 | -10.09% |
| 31 Dec, 20 | 16,024,084 | 36.02% |
| 30 Sep, 20 | 11,780,758 | 7.82% |
| 30 Jun, 20 | 10,926,164 | - |
Keros Therapeutics (KROS) has 14.30M shares outstanding as of 30 Jun 24, down -54.40% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 48.57% | 0.45% |
| 31 Mar, 24 | 104.10% | 1.38% |
| 31 Dec, 23 | 86.73% | 1.46% |
| 30 Sep, 23 | 77.04% | 1.23% |
| 30 Jun, 23 | 79.00% | 1.31% |
| 31 Mar, 23 | 77.54% | 1.26% |
| 31 Dec, 22 | 78.38% | 1.57% |
| 30 Sep, 22 | 70.74% | 1.36% |
| 30 Jun, 22 | 72.15% | 1.54% |
| 31 Mar, 22 | 68.53% | 1.44% |
| 31 Dec, 21 | 68.92% | 1.98% |
| 30 Sep, 21 | 59.05% | 1.61% |
| 30 Jun, 21 | 60.56% | 1.57% |
| 31 Mar, 21 | 62.02% | 1.13% |
| 31 Dec, 20 | 74.11% | 2.17% |
| 30 Sep, 20 | 58.39% | 1.52% |
| 30 Jun, 20 | 62.00% | - |
As of 30 Jun 24, Keros Therapeutics is held by 48.57% institutional shareholders, representing a 0.45% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 37 | -61.05% |
| 31 Mar, 24 | 95 | 37.68% |
| 31 Dec, 23 | 69 | 38.00% |
| 30 Sep, 23 | 50 | -32.43% |
| 30 Jun, 23 | 74 | 5.71% |
| 31 Mar, 23 | 70 | -7.89% |
| 31 Dec, 22 | 76 | 24.59% |
| 30 Sep, 22 | 61 | -1.61% |
| 30 Jun, 22 | 62 | 24.00% |
| 31 Mar, 22 | 50 | -3.85% |
| 31 Dec, 21 | 52 | 20.93% |
| 30 Sep, 21 | 43 | -15.69% |
| 30 Jun, 21 | 51 | 8.51% |
| 31 Mar, 21 | 47 | -31.88% |
| 31 Dec, 20 | 69 | 200.00% |
| 30 Sep, 20 | 23 | -54.90% |
| 30 Jun, 20 | 51 | - |
37 institutional shareholders have increased their position in KROS stock as of 30 Jun 24 compared to 95 in the previous quarter (a -61.05% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 21 | -43.24% |
| 31 Mar, 24 | 37 | 19.35% |
| 31 Dec, 23 | 31 | 6.90% |
| 30 Sep, 23 | 29 | 16.00% |
| 30 Jun, 23 | 25 | -24.24% |
| 31 Mar, 23 | 33 | 10.00% |
| 31 Dec, 22 | 30 | 30.43% |
| 30 Sep, 22 | 23 | 21.05% |
| 30 Jun, 22 | 19 | -26.92% |
| 31 Mar, 22 | 26 | - |
| 31 Dec, 21 | 26 | - |
| 30 Sep, 21 | 26 | 62.50% |
| 30 Jun, 21 | 16 | -33.33% |
| 31 Mar, 21 | 24 | 300.00% |
| 31 Dec, 20 | 6 | -60.00% |
| 30 Sep, 20 | 15 | - |
| 30 Jun, 20 | - | - |
21 institutional shareholders have reduced their position in KROS stock as of 30 Jun 24 compared to 37 in the previous quarter (a -43.24% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 73 | -51.33% | 14,302,112 | -54.40% | 48.57% | 0.45% | 37 | -61.05% | 21 | -43.24% |
| 31 Mar, 24 | 150 | 23.97% | 31,360,893 | 21.87% | 104.10% | 1.38% | 95 | 37.68% | 37 | 19.35% |
| 31 Dec, 23 | 121 | 14.15% | 25,732,585 | 12.83% | 86.73% | 1.46% | 69 | 38.00% | 31 | 6.90% |
| 30 Sep, 23 | 106 | -13.82% | 22,805,528 | 1.76% | 77.04% | 1.23% | 50 | -32.43% | 29 | 16.00% |
| 30 Jun, 23 | 123 | -6.11% | 22,410,603 | 1.88% | 79.00% | 1.31% | 74 | 5.71% | 25 | -24.24% |
| 31 Mar, 23 | 131 | 3.15% | 21,997,549 | 11.19% | 77.54% | 1.26% | 70 | -7.89% | 33 | 10.00% |
| 31 Dec, 22 | 127 | 13.39% | 19,783,180 | 9.46% | 78.38% | 1.57% | 76 | 24.59% | 30 | 30.43% |
| 30 Sep, 22 | 112 | 9.80% | 18,073,618 | 4.14% | 70.74% | 1.36% | 61 | -1.61% | 23 | 21.05% |
| 30 Jun, 22 | 102 | -3.77% | 17,354,802 | 5.54% | 72.15% | 1.54% | 62 | 24.00% | 19 | -26.92% |
| 31 Mar, 22 | 106 | 7.07% | 16,443,720 | 1.81% | 68.53% | 1.44% | 50 | -3.85% | 26 | - |
| 31 Dec, 21 | 99 | 13.79% | 16,151,318 | 17.08% | 68.92% | 1.98% | 52 | 20.93% | 26 | - |
| 30 Sep, 21 | 87 | 11.54% | 13,795,249 | -2.26% | 59.05% | 1.61% | 43 | -15.69% | 26 | 62.50% |
| 30 Jun, 21 | 78 | -6.02% | 14,114,722 | -2.03% | 60.56% | 1.57% | 51 | 8.51% | 16 | -33.33% |
| 31 Mar, 21 | 83 | 3.75% | 14,407,813 | -10.09% | 62.02% | 1.13% | 47 | -31.88% | 24 | 300.00% |
| 31 Dec, 20 | 80 | 63.27% | 16,024,084 | 36.02% | 74.11% | 2.17% | 69 | 200.00% | 6 | -60.00% |
| 30 Sep, 20 | 49 | -3.92% | 11,780,758 | 7.82% | 58.39% | 1.52% | 23 | -54.90% | 15 | - |
| 30 Jun, 20 | 51 | - | 10,926,164 | - | 62.00% | - | 51 | - | - | - |
Keros Therapeutics Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
All Insider Owners Trades
The last insider sell of Keros Therapeutics's stock was made by GORDON CARL L on Aug 15 2024, selling 220,600 shares at $44.01 per share (valued at $9.71M).
Keros Therapeutics Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | - | 4 | - |
| Q2 2024 | 8 | 1 | 800.00% |
| Q1 2024 | 5 | 1 | 500.00% |
| Q4 2023 | 1 | 1 | 100.00% |
| Q2 2023 | 10 | 8 | 125.00% |
| Q1 2023 | 4 | - | - |
| Q4 2022 | - | 12 | - |
| Q3 2022 | - | 4 | - |
| Q2 2022 | 15 | 16 | 93.75% |
| Q1 2022 | 9 | 38 | 23.68% |
| Q4 2021 | 5 | 67 | 7.46% |
| Q3 2021 | 2 | 17 | 11.76% |
| Q2 2021 | 16 | 94 | 17.02% |
| Q1 2021 | 9 | 113 | 7.96% |
| Q4 2020 | 13 | - | - |
| Q2 2020 | 74 | 34 | 217.65% |
0 total buy trades, and 4 total sell trades (buy/sell ratio of 0.00%) were made by Keros Therapeutics's insiders, as of Q3 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | - | 4 | - |
| Q2 2024 | - | - | - |
| Q1 2024 | - | - | - |
| Q4 2023 | - | 1 | - |
| Q2 2023 | - | 5 | - |
| Q1 2023 | - | - | - |
| Q4 2022 | - | - | - |
| Q3 2022 | - | 2 | - |
| Q2 2022 | - | 9 | - |
| Q1 2022 | - | 32 | - |
| Q4 2021 | - | 62 | - |
| Q3 2021 | - | 16 | - |
| Q2 2021 | - | 84 | - |
| Q1 2021 | - | 108 | - |
| Q4 2020 | 12 | - | - |
| Q2 2020 | 18 | - | - |
As of Q3 2024, Insider owners conducted 0 open market buy trades and 4 open market sell trades of Keros Therapeutics's stocks.
Keros Therapeutics Peer Ownership
| Ticker | Company |
|---|---|
| ANAB | AnaptysBio, Inc. |
| NGM | NGM Biopharmaceuticals, Inc. |
| IDYA | IDEAYA Biosciences, Inc. |
| LRMR | Larimar Therapeutics, Inc. |
| MLYS | Mineralys Therapeutics, Inc. |
| EWTX | Edgewise Therapeutics, Inc. |
| MGTX | MeiraGTx Holdings plc |
| IPSC | Century Therapeutics, Inc. |
| AVTE | Aerovate Therapeutics, Inc. |
| ERAS | Erasca, Inc. |
| REPL | Replimune Group, Inc. |
| FENC | Fennec Pharmaceuticals Inc. |
| SRZN | Surrozen, Inc. |
| SNDX | Syndax Pharmaceuticals, Inc. |
| JANX | Janux Therapeutics, Inc. |
| BOLT | Bolt Biotherapeutics, Inc. |
| HRMY | Harmony Biosciences Holdings, Inc. |
| GLUE | Monte Rosa Therapeutics, Inc. |
| KZR | Kezar Life Sciences, Inc. |
| FIXX | Q32 Bio Inc. |
KROS Ownership FAQ
Who Owns Keros Therapeutics?
Keros Therapeutics is owned by institutional shareholders (48.57%), insiders (5.86%), and public (45.57%). The largest institutional shareholder of Keros Therapeutics is FMR LLC (16.03% of total shares) and the top mutual fund owner is Tema ETF Trust (0.21% of total shares).
Who are the major institutional shareholders of Keros Therapeutics?
Keros Therapeutics's major institutional shareholders are FMR LLC, BLACKROCK INC., VANGUARD GROUP INC, ALKEON CAPITAL MANAGEMENT LLC, and DARWIN GLOBAL MANAGEMENT, LTD.. The top five shareholders own together 41.14% of the company's share outstanding.
How many Keros Therapeutics shareholders are there?
As of Jun 2024, there are 73 institutional shareholders of Keros Therapeutics.
What percentage of Keros Therapeutics is owned by FMR LLC?
FMR LLC owns 4.72M shares of Keros Therapeutics, representing 16.03% of the company's total shares outstanding, valued at $215.69M (as of Jun 2024).
What percentage of Keros Therapeutics is owned by BLACKROCK INC?
As of Jun 2024, BLACKROCK INC holds 2.51M shares of Keros Therapeutics (KROS), compromising 8.53% of the company, valued at $114.86M.
What percentage of Keros Therapeutics is owned by VANGUARD GROUP INC?
VANGUARD GROUP INC is the third largest holder of Keros Therapeutics. The company owns 1.76M of the company's shares outstanding (worth $80.3M).